IPP Bureau
Borosil Scientific to shift unit at Ambad to Bharuch
By IPP Bureau - February 27, 2025
This will lead to the consolidation and optimization of the company's operations related to the manufacturing of ampoules and vials
USFDA issues Form 483 with 3 observations to Gland Pharma's Sterile APIs unit
By IPP Bureau - February 27, 2025
The observations issued are neither repeated observations nor related to data integrity
Briefs: Emcure and Relonchem
By IPP Bureau - February 27, 2025
USFDA inspection at Emcure Pharmaceuticals API facility
Caplin Steriles receives USFDA final approval for ANDA Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
By IPP Bureau - February 27, 2025
Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure
Senores Pharmaceuticals begins operations at greenfield API facility
By IPP Bureau - February 27, 2025
This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.
Venus Remedies secures in-licensing rights from Infex Therapeutics to develop and commercialize MET-X in India
By IPP Bureau - February 27, 2025
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Glenmark Pharmaceuticals USA launches Epinephrine Injection USP
By IPP Bureau - February 27, 2025
This launch of Epinephrine Injection multiple-dose Vial is eligible for 180 days of CGT exclusivity under section 505(j)(5)(B)(v) of the FD&C Act.
India’s CRDMO sector growth potential at $22 - $25 Billion by 2035: BCG-IPSO Report
By IPP Bureau - February 26, 2025
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
Merck unveils formulation and technology center in Navi Mumbai
By IPP Bureau - February 26, 2025
The Formulation & Technology Centre intends to function as a technology storefront, offering advanced formulation and processing solutions to address the growing demand for complex drug formulations
Cadila Pharmaceuticals opens advanced pharmaceutical warehouse
By IPP Bureau - February 26, 2025
FDA grants EUA to Aptitude’s Covid/flu multiplex test for OTC use
By IPP Bureau - February 26, 2025
Amgen opens new technology and innovation site in Hyderabad
By IPP Bureau - February 25, 2025
Amgen India investment totals $200 million through 2025
Biocon Biologics launches Yesintek Biosimilar to Stelara in US
By IPP Bureau - February 25, 2025
YESINTEK is approved for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis
Indegene launches AI platform Cortex
By IPP Bureau - February 25, 2025
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Teva and Sanofi present new outcome from Phase 2b study of duvakitug
By IPP Bureau - February 25, 2025
Findings to form the basis for a Phase 3 program, anticipated to start in H2 2025
